Departments providing services remotely. Building access limited. Check uml.edu/alert for more info.
Dear UMass Lowell Researchers,
As a result of the COVID-19 pandemic and subsequent state advisories from the Governor, all research activities on campus are suspended with the exception of pre-approved critical equipment maintenance, animal care and COVID-19 responsive activities.
As such, the Office of Research and Innovation has prepared a statement to provide to sponsors and collaborators if requested: Statement Regarding Suspension of UMass Lowell On-campus Research in Response to COVID-19
In addition, UMass Lowell is working with the state’s Advanced Manufacturing Emergency Response Team and will be directing people to further information as we marshal all of our capabilities to support this coordinated effort. If you are interested in helping and have either expertise or equipment that may be useful, please complete the online survey.
Please also carefully review the research FAQ which is continuously updated on the Guidance for Campus Research in response to COVID-19 webpage.
Thank you for your cooperation as we all work through these challenges together. If you have any questions or suggestions, please email: VCRI@uml.edu.
Please review all the COVID-19 research announcements.
The University of Massachusetts Lowell Office of Technology Commercialization (OTC) supports the commercialization of inventions emerging from research conducted at UMass Lowell. OTC provides researchers with the support to analyze and achieve the full potential of their inventions and to develop a commercialization plan for each technology. Innovative technologies from UMass Lowell are licensed to all types of companies, ranging from enterprising start-ups to large multinational corporations. OTC-generated revenues help to sustain the University's mission of scientific research and economic development.